KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares IssuedShares Repurchased
Ratios

Regeneron Pharmaceuticals (REGN) Shares Repurchased (2018 - 2025)

Historic Shares Repurchased for Regeneron Pharmaceuticals (REGN) over the last 8 years, with Q4 2025 value amounting to $671.7 million.

  • Regeneron Pharmaceuticals' Shares Repurchased fell 3096.61% to $671.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $3.4 billion, marking a year-over-year increase of 3208.62%. This contributed to the annual value of $3.4 billion for FY2025, which is 3208.62% up from last year.
  • Latest data reveals that Regeneron Pharmaceuticals reported Shares Repurchased of $671.7 million as of Q4 2025, which was down 3096.61% from $664.0 million recorded in Q3 2025.
  • Regeneron Pharmaceuticals' Shares Repurchased's 5-year high stood at $1.1 billion during Q2 2025, with a 5-year trough of $166.4 million in Q3 2021.
  • Over the past 5 years, Regeneron Pharmaceuticals' median Shares Repurchased value was $633.9 million (recorded in 2024), while the average stood at $600.3 million.
  • As far as peak fluctuations go, Regeneron Pharmaceuticals' Shares Repurchased tumbled by 9395.99% in 2021, and later skyrocketed by 46165.87% in 2022.
  • Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Shares Repurchased stood at $866.9 million in 2021, then plummeted by 50.27% to $431.1 million in 2022, then plummeted by 32.96% to $289.0 million in 2023, then surged by 236.68% to $973.0 million in 2024, then plummeted by 30.97% to $671.7 million in 2025.
  • Its Shares Repurchased was $671.7 million in Q4 2025, compared to $664.0 million in Q3 2025 and $1.1 billion in Q2 2025.